Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
942.55
3.35 (0.36%)
< Home < Back

Zydus Lifesciences informs about press release

Date: 05-11-2025
Zydus Lifesciences has informed that it enclosed a copy of press release dated November 5, 2025, titled ‘Zydus receives EIR for SEZ II manufacturing facility, Ahmedabad’. The contents of the press release give full details. The aforesaid news to the notice of the members of the exchange and the investors’ at large.

The above information is a part of company’s filings submitted to BSE.